Wordt geladen...
Potential Cost Implications for All US Food and Drug Administration Oncology Drug Approvals in 2018
IMPORTANCE: The growth of cancer drug spending in the US has outpaced spending in nearly all other sectors, and an increasing proportion of the drug development pipeline is devoted to oncology. In 2018, there was a record number of drugs entering the US market. OBJECTIVE: To estimate the number of p...
Bewaard in:
| Gepubliceerd in: | JAMA Intern Med |
|---|---|
| Hoofdauteurs: | , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
American Medical Association
2020
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7653539/ https://ncbi.nlm.nih.gov/pubmed/33165499 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jamainternmed.2020.5921 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|